Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Ken Tian"'
Autor:
Adam S. Kibel, Martin Gleave, Sabine D. Brookman-May, Won Kim, Christopher P. Evans, Eleni Efstathiou, Philip W. Kantoff, Ashley Ross, Neal D. Shore, Alberto Briganti, Boris A. Hadaschik, Axel Heidenreich, Oliver Brendan Rooney, Shaozhou Ken Tian, Lisa Wetherhold, Weichun Xu, J. Kellogg Parsons, Kesav Yeruva, Mary-Ellen Taplin
TPS285 Background: In pts with localized high-risk PC, disease recurrence rate following RP is ̃50% (Kane et al. J Urol. 2007). Treatment (tx) with androgen blockade before RP can reduce tumor burden post RP (Taplin et al. J Clin Oncol. 2014; McKay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7471f5ec855334535368386ed3ab903
Autor:
Xuemin Zhang, Chantel Scheuring, Sucheta Tripathy, Zhanyou Xu, Chengcang Wu, Angela Ko, S. Ken Tian, Felipe Arredondo, Mi-Kyung Lee, Felipe A. Santos, Rays H. Y. Jiang, Hong-Bin Zhang, Brett M. Tyler
Publikováno v:
Molecular Plant-Microbe Interactions, Vol 19, Iss 12, Pp 1302-1310 (2006)
Phytophthora spp. are serious pathogens that threaten numerous cultivated crops, trees, and natural vegetation worldwide. The soybean pathogen P. sojae has been developed as a model oomycete. Here, we report a bacterial artificial chromosome (BAC)-ba
Externí odkaz:
https://doaj.org/article/d956045b76af4c38b80baf74a0fe6aab
Autor:
Justin Tepe, Alan L. Ho, Robert M. Samstein, Nora Katabi, Fengshen Kuo, Raghvendra M. Srivastava, Marc Cohen, Nadeem Riaz, Kety Huberman, Zaineb Nadeem, S. Ken Tian, Timothy A. Chan, Chirag Krishna, Richard J. Wong, Phaedra Agius, Kanika Arora, Douglas R. Hoen, Katelynd Vanness, Nancy Bouvier, Ronald Ghossein, Rajarsi Mandal, Wei Yang, Martin G. Dalin, Ken-Wing Lee, Vladimir Makarov, Jonathan J. Havel, Diego Chowell, Heather Geiger, Luc G. T. Morris, Leonard H. Wexler, Nicolas Robine, Jennifer S. Sims, Neerav Shukla, Ian Ganly
Publikováno v:
Nature medicine
Anti-tumor immunity is driven by self versus non-self discrimination. Many immunotherapeutic approaches to cancer have taken advantage of tumor neoantigens derived from somatic mutations. Here, we demonstrate that gene fusions are a source of immunog
Publikováno v:
Chinese Journal of Plant Ecology. 43:566-575
Autor:
Nataša Obermajer, Adam Zwolak, Kelly Van De Ven, Shana Versmissen, Aleksandra Brajic, Ted Petley, Dan Weinstock, Jason Aligo, Fang Yi, Stephen Jarantow, Keith Schutsky, Ken Tian, Angelilo Lorraine, Diana Alvarez Arias, Kristel Buyens, Vince Torti, Krista Menard, Katharine Rogers, Brian Geist, Marjolein Van Heerden, Gerald Chu, Bie Verbist, Maté Ongenaert, Julien Hasler, Kathryn Packman, Jacintha Shenton, Dirk Brehmer, Josh Lauring, Regina J. Brown, James Greger, Daphne Salick Ryan, Sanjaya Singh, Matthew V. Lorenzi, Laurie Lenox, Sylvie Laquerre
Publikováno v:
Cancer Research. 82:ND07-ND07
JNJ-78306358 is a first-in-class bispecific antibody (bsAb), engineered using the Zymeworks Azymetric™ platform, to treat advanced stage solid tumors. Human leukocyte antigen G (HLA-G) is a non-classical major histocompatibility class I molecule wi
Autor:
Subhasree Basu, Mike Russell, Katrin Sproesser, Bethany Mattson, Cassandra L. Lowenstein, Sathya Venkataramani, Maura Diamond, Robin E. Ernst, Stephen Jarantown, Jackson Wong, Gerald Chu, Kathryn Packman, Shaozhou Ken Tian, Scott R. Brodeur, Margaret Yu, Brent A. Rupnow
Publikováno v:
Cancer Research. 82:LB087-LB087
TMEFF2, a transmembrane protein with epidermal growth factor-like and 2 follistatin-like domains, is primarily restricted in expression to healthy brain and prostate and is enriched in prostate cancer. JNJ-70218902 (JNJ-902) is a bispecific antibody
Autor:
Pooya Mobadersany, Justin Lucas, Darshana Govind, Clemente Aguilar-Bonavides, Sharon McCarthy, Sabine Brookman-May, Margaret K. Yu, Ken Tian, Natalie Hutnick, Jose Zamalloa, Joel Greshock, Najat Khan, Stephen S.F. Yip
Publikováno v:
Cancer Research. 82:5053-5053
Objective: AI has demonstrated great promise in learning sophisticated features and relations in data that would otherwise remain hidden to the human eye. Here, we developed a proprietary AI-based multimodal approach to integrate clinical, digitized
Autor:
Robert B. Darnell, Ryma Benayed, Stephen S. Roberts, Jaclyn F. Hechtman, Andrew L. Kung, Nora Ku, Ken Tian, José Baselga, Ahmet Zehir, Marc Ladanyi, Elli Papaemmanuil, David M. Hyman, Qazi Mushtaq, Kristie Redfield, Alexander Drilon, Paul E. Goss, Gunes Gundem, Mollah O. Baki, Heather Geiger, Ben Ho Park, Neerav Shukla, Gerald Behr
Publikováno v:
JCO Precision Oncology. :1-8
Autor:
Shaozhou Ken Tian1, Killian, J. Keith1, Rekhtman, Natasha1, Benayed, Ryma1, Middha, Sumit1, Ladanyi, Marc1, Lin, Oscar1, Arcila, Maria E.1 arcilam@mskcc.org
Publikováno v:
Archives of Pathology & Laboratory Medicine. Nov2016, Vol. 140 Issue 11, p1200-1205. 6p. 2 Diagrams, 2 Graphs.
Autor:
Mary-Ellen Taplin, Martin Gleave, Christopher P. Evans, Eleni Efstathiou, Philip W. Kantoff, Ashley Ross, Neal D. Shore, Alberto Briganti, Boris A. Hadaschik, Axel Heidenreich, Oliver Brendan Rooney, Shaozhou Ken Tian, Lisa Wetherhold, Weichun Xu, Shinta Cheng, Adam S. Kibel
TPS5100 Background: Patients (pts) with localized high-risk PC experience disease progression rates of approximately 50% after RP (Kane et al. J Urol. 2007). With the approval of next-generation androgen receptor inhibitors, neoadjuvant studies have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2055af4a9337c3327b3c09e7e221ce47